Skip to content

Patient-Controlled Sedation Versus Anesthesiologist-Administered Sedation

A Phase IV, Randomized, Double-Blind, Controlled Study of the Effects of Patient-Controlled Sedation vs. Anesthesiologist-Administered Sedation With Propofol and Remifentanil on Rate of Disordered Breathing in Subjects Undergoing Elective Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00868920
Enrollment
50
Registered
2009-03-25
Start date
2008-01-31
Completion date
2009-03-31
Last updated
2017-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Brief summary

The purpose of this study is to see whether patients controlling their own sedation during colonoscopy are less likely to need help breathing than when an anesthesiologist controls the medicine, and whether we can predict when the need for help will occur. The pump used in the study is approved for clinical use by the FDA, as are the medicines used in the pump.

Interventions

OTHERpatient control of pump

Patient controls sedation pump during colonoscopy.

OTHERanesthesiologist controlled sedation

Anesthesiologist will control the sedation pump during colonoscopy.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

1. Undergoing elective, outpatient colonoscopy 2. Age ≥ 18, \<90 3. Meet criteria for conscious sedation (HUP Policy 1-12-11, Appendix F), as determined by the attending gastroenterologist and confirmed by the anesthesiologist by review of history 4. Able to give informed consent

Exclusion criteria

1. Have a history of allergy or adverse reaction to propofol or remifentanil 2. Have a condition which would pose an elevated risk for administration of propofol, including primary hyperlipoproteinemia, diabetic hyperlipemia, and pancreatitis. 3. Female of child-bearing potential (under 50 without surgical sterilization) 4. Unable to understand the use of Patient Contolled Sedation

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the depth of sedation,during colonoscopy procedure

Secondary

MeasureTime frame
The secondary outcome measure is rate of respiratory depressionduring colonoscopy procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026